Gitte Persson Profile
Gitte Persson

@GittePersson

Followers
259
Following
636
Media
16
Statuses
148

Clinical oncologist from Copenhagen with focus on lung cancer, radiotherapy and research.

Joined October 2010
Don't wanna be here? Send us removal request.
@ESTRO_RT
ESTRO
2 years
๐Ÿ“… The #ESTROSchool Calendar for the 2024 Teaching Courses is now AVAILABLE! Explore our 32 post-graduate courses, designed for all disciplines of RT: https://t.co/EfCn5HeKHX ๐Ÿ‘‰Register for live or online courses, tailored to elevate your expertise: https://t.co/mCk4syw2d0 #MedEd
0
26
73
@finn_corinne
Corinne Faivre-Finn
4 years
Further evidence on the causal relation between heart irradiation and survival of lung cancer from Odense with collaboration from @TheChristieNHS @RT_physics
1
15
50
@GittePersson
Gitte Persson
4 years
This is what inspired our ESO-SPARE CRT of esophagus sparing IMRT or VMAT for MSCC ,included 80/200 patients.@IvanVogelius @MSuppli @Helle_PP @HerlevGentofte @Rigshospitalet Claus Behrens, Patrik Sibolt, @Lotte_E_N
@MSuppli
Morten Hiul Suppli
4 years
@GittePersson @LotteSFog Vanja Remberg Grams project is published here
0
0
6
@GittePersson
Gitte Persson
4 years
Helpful advices from @LNivisonSmith on how to progress on tasks.
@LNivisonSmith
Dr Lisa Nivison-Smith
4 years
Manuscript drafts ๐Ÿ“ Peer reviews ๐Ÿ“‘ Emails ๐Ÿ“ง Academia is notorious for being late How to stick to a writing deadline A thread๐Ÿงต @AcademicChatter @PhD_Genie @OpenAcademics
1
0
2
@GittePersson
Gitte Persson
4 years
Its an insurmountable task for many seniors in academia to keep up with emails. The recommendations from @LNivisonSmith are formidable. Thanks for the retweet @stinekorreman
@LNivisonSmith
Dr Lisa Nivison-Smith
4 years
As a PhD student, my supervisor never answered my emails. Then I became a PhD supervisor and realised why A thread๐Ÿงต of my mistakes and how to avoid them #phdchat #AcademicTwitter
0
0
2
@GittePersson
Gitte Persson
4 years
Yes! #RTTs need to be involved in clinical trial - preferably from the start. Our RCT for MSCC ESO-spare is based on data from RTT Vanja Remberg Gramโ€™s RTT project That was initiated together with #medphys @LotteSFog ๐Ÿ’ช
1
0
10
@GittePersson
Gitte Persson
4 years
Congratulations to @ESTRO_RT for electing a(n) (honorary) physicist for president๐Ÿ™Œ Well deserved honor to the incredibly hard working and excellent @Mat_Guc who has contributed in so many ways to the #radonc society. #ESTRO2022 #ESTRO22
@PBlanchardMD
Pierre Blanchard, MD
4 years
Congrats to @Mat_Guc for being elected as @ESTRO_RT president (elect, for the moment) @AnnaKirby17 becomes president for 2 years, & @bslotman past president. Thanks to the three of them for all they do for the Society & #radonc community at large. ๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™๐Ÿ™
0
0
9
@GittePersson
Gitte Persson
4 years
@krause_moeller collected PRO data in SOFT
0
1
3
@GittePersson
Gitte Persson
4 years
Well done @FelterMette๐Ÿ’ช Nice presentation of target characteristics from the multicenter SOFT trial of MR-guided SBRT of infra-diafragmatic soft tissue oligo mets. Early tox data are soon mature @IvanVogelius @TineSchytte @radoncbme @MettePoel @MirjanaMedPhys and many more
3
1
18
@GittePersson
Gitte Persson
4 years
Reflects the impact of advances in technology
@azza64
azza khalil
4 years
Clara Chan shows that survival of lung cancer patients improves significantly with time even though the GTV volumes are larger #ESTRO2022
0
0
1
@azza64
azza khalil
4 years
Clara Chan shows that survival of lung cancer patients improves significantly with time even though the GTV volumes are larger #ESTRO2022
0
1
3
@GittePersson
Gitte Persson
4 years
So proud of Nicklas Spindler, who presented our very first data from the Bony-M trial of SBRT for bony OMD with patients from Denmark and Norway @FelterMette @MSuppli @laurids_poulsen med flere
1
2
18
@GittePersson
Gitte Persson
4 years
The very last Honorary Physicist is the amazing @finn_corinne, who is leading practice changing research in lung cancer radiotherapy. Congratulations! Very well deserved. I support your call for a physicist or RT as president๐Ÿ’ช #ESTRO2022 @ESTRO_RT
0
0
12
@MSuppli
Morten Hiul Suppli
4 years
Photons vs protons in NSCLC, diff in lymfopenia and correlated to bone marrow dose. Does it mitigate to diff in survival? Danish HERAN2 trial in fragile patients with NSCLC will try to answer this. #ESTRO2022 @DCPTprotons @azza64 @DitteSloth @mettepohl @DCCC_RT
0
9
19
@Mat_Guc
Matthias Guckenberger
4 years
Long-term survival data of the SABR COMET trial presented by @drdavidpalma #ESTRO2022 WOW ๐Ÿ‘
1
68
251
@MSuppli
Morten Hiul Suppli
4 years
Early toxicity after SABR in oligometastatic bone metastasis in the BONY-M trial, presented by Dr Spindler๐Ÿ•บin D3 at 17.45 Sunday recruited from @HerlevGentofte @Rigshospitalet @onko_ouh @AalborgUH @FelterMette @GittePersson @laurids_poulsen #ESTRO2022 #radonc
1
1
9
@DCCC_RT
DCCC_Radiotherapy
4 years
Course report by @FelterMette, clinical oncologist & PhD student. Takeaways: Implementation & practice of IGSBRT is a multidisciplinary work effort. Don't underestimate importance of refining treatment technique. Close attention to dose prescription and margin calc. is worthwhile
@ESTRO_RT
ESTRO
4 years
#ESTROnewsletter Course Reports: Implementation and Practice of Image-Guided Stereotactic Body Radiotherapy https://t.co/y9oTlHU6pi
0
1
7
@gerryhanna
Gerry Hanna
4 years
@finn_corinne @TheLancetOncol Looks really promising!
0
1
2
@GittePersson
Gitte Persson
4 years
ART reduces toxicity and increases PFS and OS in LC RT. Modern technology translated into improved cancer survival. Excellent work by the AUH group. โฆ@azza64โฉ โฆ@DCCC_RTโฉ
Tweet card summary image
thegreenjournal.com
Locally advanced non-small cell lung cancer (LA-NSCLC) is routinely treated with concurrent chemo-radiotherapy. Despite an intensive treatment strategy with risk of severe toxicity [1โ€“4], two-year...
1
7
32